GLP-1 Weight Loss in Montgomery, AL: Alabama's Highest Obesity Rate Meets a Cash Market With Almost No Published Prices
Montgomery's 46.4% obesity rate, Alabama's 7/1/2026 PDL exclusions, one storefront price and one price-opaque clinic, and an 81,714-person low-income shortage.
46.4% of Montgomery adults have obesity (CDC PLACES 2025 release, BRFSS 2023) 1 against Alabama's own 39.2% state rate 2, a 7.2-point gap on top of a state already among the highest in the country.
Montgomery is a city of 195,826 inside a 386,587-person metro, with a median household income of $59,292 and roughly 9.1% uninsured 3456.
Montgomery County carries active HRSA Primary Care shortage designations at two levels: a county-wide Low-Income Population HPSA ('LI-Montgomery,' score 17, designated 7/6/2022, last updated 9/22/2025) covering a designation population of 81,714 with an estimated 30,258 underserved low-income residents, 19.2% of the designation population below the poverty line, and a population-to-provider ratio of 4,764:1 — plus a facility-level Primary Care HPSA at Health Services Inc. (a Montgomery FQHC at 1845 Cherry St), score 20, designated 2003. The same FQHC also carries a Mental Health facility HPSA (score 22) and a Dental Health facility HPSA (score 25), both re-verified 9/22/2025. Montgomery's shortage designations concentrate on the safety-net/low-income population rather than the city at large — but that population is over 80,000, roughly 40% of the city.8910
Specialist access
HRSA's HPSA framework does not score a specialist-tier shortage category — only Primary Care, Dental Health, and Mental Health are designated; there is no federal endocrinology/bariatric shortage measure to cite directly. The documented underlying gap is Primary Care: the county-wide Low-Income Population HPSA (score 17, 30,258 estimated underserved, 4,764:1 provider ratio) typically compounds specialist referral wait times even though it isn't a direct specialist measure. A direct check of Baptist Health Montgomery's public service-line page found no bariatric surgery or endocrinology program among its listed specialties (cardiology, women's health, orthopaedics, cancer care, neurology, primary care) — inconclusive, not a confirmed absence, since a deeper site crawl wasn't performed. Net: specialist access for obesity-specific care is a genuine data gap, not a claim either way.8
Medicaid coverage note
Alabama has not expanded Medicaid under the ACA, and its Preferred Drug List (effective 7/1/2026) excludes GLP-1 medications for weight-loss-only use: Zepbound is 'non-covered for weight reduction' outside its obstructive-sleep-apnea indication, and Wegovy is 'non-covered for weight reduction' outside its cardiovascular/MASH indications. Even diabetic-indication use of semaglutide/tirzepatide brands (Ozempic, Mounjaro, etc.) carries a 'preferred with clinical criteria' gate, not automatic coverage. Combined with Montgomery's roughly 9% uninsured rate (city, ACS 2024 1-yr) and the county's HRSA-designated low-income care gap (30,258 estimated underserved), most Montgomery residents seeking GLP-1 therapy for weight loss are effectively cash-pay regardless of insurance status — the same position Astra's transparent national self-pay pricing addresses.11
Alabama's 7/1/2026 Preferred Drug List, and what it leaves out
Alabama has not expanded Medicaid under the ACA, and its Preferred Drug List effective 7/1/2026 excludes GLP-1 medications for weight-loss-only use: Zepbound is "non-covered for weight reduction" outside its obstructive-sleep-apnea indication, and Wegovy is "non-covered for weight reduction" outside its cardiovascular/MASH indications 11.
Even diabetic-indication use of semaglutide and tirzepatide brands (Ozempic, Mounjaro, and others) carries a "preferred with clinical criteria" gate rather than automatic coverage 11. Combined with Montgomery's roughly 9% uninsured rate 6 and the county's HRSA-designated low-income care gap of 30,258 estimated underserved residents 8, most Montgomery residents seeking GLP-1 therapy for weight loss are effectively cash-pay regardless of insurance status.
What GLP-1 care costs in Montgomery today
Optimize Medical Weight Loss & Wellness, LLC, at 7715 Averiett Dr, is the one Montgomery clinic running a live WooCommerce storefront with checkout-ready GLP-1 pricing: "Sema 0.5" (semaglutide, 0.5mg) at $266.73/mo, "Semaglutide 1 mg" at $289.65/mo, and "Tirzep" (tirzepatide) at $368.70/mo, with no separate bundled program fee disclosed. Confirmed live on direct fetch, checked 2026-08-28 13.
Down With The Pounds Medical Weight Loss And More, Inc., at 1321 Old Oak Pl, advertises physician-monitored GLP-1/GLP-2 injections but publishes no price for GLP-1, semaglutide, or tirzepatide anywhere on its site, including its dedicated GLP-1 info page, where GLP-1 appears only as an inquiry option in a contact-form dropdown 14. Its separate "Shot Bar" page prices only non-GLP-1 vitamin and lipotropic shots (Yolanda Shot $55, Super MIC $55, Glutathione $34, MIC Booster $25, L-Carnitine 500mg $20, B Complex $15, B12 Booster $18, Lipo B $28), which shows the GLP-1 opacity is a deliberate omission, not a site-wide non-disclosure policy 15. A BBB search under weight-loss and weight-reduction-physician categories for Montgomery turned up no additional in-city clinic publishing GLP-1 prices 12.
Astra's national price is $68/month for semaglutide and $118/month for tirzepatide on 12-month plans, the same in every city Astra serves.
An 81,714-person shortage designation, and a specialist picture nobody can document
Montgomery County carries active HRSA Primary Care shortage designations at two levels: a county-wide Low-Income Population HPSA ("LI-Montgomery," score 17, designated 7/6/2022, last updated 9/22/2025) covering a designation population of 81,714 with an estimated 30,258 underserved low-income residents, 19.2% of that population below the poverty line, and a population-to-provider ratio of 4,764:1, plus a facility-level Primary Care HPSA at Health Services Inc., a Montgomery FQHC at 1845 Cherry St, score 20, designated 2003 8. The same FQHC carries a Mental Health facility HPSA (score 22) and a Dental Health facility HPSA (score 25), both re-verified 9/22/2025 910. These designations concentrate on the safety-net population rather than the city at large, but that population is over 80,000, roughly 40% of the city.
HRSA's framework does not score a specialist tier, so there is no federal endocrinology or bariatric shortage measure to cite 8. A direct check of Baptist Health Montgomery's public service-line page found no bariatric surgery or endocrinology program among its listed specialties (cardiology, women's health, orthopaedics, cancer care, neurology, primary care), which is inconclusive rather than a confirmed absence, since a deeper site crawl wasn't performed. Specialist access for obesity-specific care in Montgomery is a genuine data gap, not a claim either way.
What is documented is the primary-care bottleneck at a 4,764:1 ratio, which is where most GLP-1 prescribing starts. Telehealth answers that directly. See the Alabama GLP-1 overview for statewide context.
Astra treats patients in Alabama through state-licensed physicians.
Local options
Optimize Medical Weight Loss & Wellness, LLC (7715 Averiett Dr, Montgomery, AL 36116) — Runs a live WooCommerce storefront with checkout-ready GLP-1 pricing: 'Sema 0.5' (semaglutide, 0.5mg) $266.73/mo, 'Semaglutide 1 mg' $289.65/mo, 'Tirzep' (tirzepatide) $368.70/mo — no separate bundled program fee disclosed. Confirmed live on direct fetch. https://optimizemedical.org/shop/(checked 2026-08-28)
Down With The Pounds Medical Weight Loss And More, Inc. (1321 Old Oak Pl, Montgomery, AL 36117) — Advertises physician-monitored GLP-1/GLP-2 injections but publishes no price for GLP-1, semaglutide, or tirzepatide anywhere on the site, including its dedicated GLP-1 info page — GLP-1 appears only as an inquiry option in a contact-form dropdown. Its separate 'Shot Bar' page prices only non-GLP-1 vitamin/lipotropic shots (Yolanda Shot $55, Super MIC $55, Glutathione $34, MIC Booster $25, L-Carnitine 500mg $20, B Complex $15, B12 Booster $18, Lipo B $28), confirming the GLP-1 opacity is a deliberate omission, not a site-wide non-disclosure policy. https://www.downwiththepounds.com/index.php/en/glp1-injection-info(checked 2026-08-28)
Frequently asked questions
How much does semaglutide or tirzepatide cost in Montgomery, AL?
Locally, prices are largely undisclosed. Only one Montgomery clinic found with published GLP-1 pricing, Optimize Medical Weight Loss & Wellness, lists semaglutide at $266.73–$289.65/month and tirzepatide at $368.70/month on its own checkout page (checked Aug 28, 2026). A second clinic, Down With The Pounds, advertises GLP-1 injections but publishes no price at all. Astra's national self-pay price is $68/month for semaglutide and $118/month for tirzepatide on a 12-month plan ($816/$1,416 billed annually) — the same price in Montgomery as in every other city Astra serves.
Is Astra cheaper than local Montgomery clinics?
Where a Montgomery clinic actually publishes a price, yes: Optimize Medical's checkout prices ($266.73–$368.70/month) run roughly 3–4x Astra's national annual-plan rate ($68/month semaglutide, $118/month tirzepatide). We can't compare against Down With The Pounds because it doesn't publish a GLP-1 price to compare against — which is itself worth knowing before you call around.
Does Alabama Medicaid cover GLP-1 weight-loss drugs like Wegovy or Zepbound in Montgomery?
No, not for weight loss. Alabama's Medicaid Preferred Drug List (effective 7/1/2026) states Zepbound is 'non-covered for weight reduction' outside its sleep-apnea indication and Wegovy is 'non-covered for weight reduction' outside its cardiovascular/MASH indications. Even diabetic-indication use of semaglutide/tirzepatide brands requires meeting documented clinical criteria — coverage isn't automatic. Alabama has also not expanded Medicaid under the ACA.
Is Montgomery, Alabama a health professional shortage area?
Yes, for primary care. HRSA designates a county-wide Low-Income Population Primary Care HPSA (score 17) covering 81,714 residents, with about 30,258 estimated underserved and a 4,764-to-1 population-to-provider ratio — plus a facility-level HPSA at the city's core FQHC, Health Services Inc. There's no federal shortage category for endocrinology or bariatric specialists specifically, so specialist access couldn't be independently confirmed either way.
Why is Montgomery's obesity rate so much higher than the Alabama state average?
Montgomery's adult obesity rate is 46.4% (CDC PLACES, BRFSS 2023, crude prevalence) versus Alabama's own statewide rate of 39.2% — a 7.2-point gap on top of a state that's already consistently among the top five in the country for adult obesity. We don't have a single sourced cause for that local gap; what is documented is that it sits alongside a real primary-care shortage and a largely price-opaque local weight-loss market, both of which limit access to treatment regardless of the cause.